Financials
- Market Capitalization 15.92 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.36
ratio cours/chiffre d'affaires
1.92
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4621 | BIVI BioVie Inc. - Common stock | 2.28 USD | +5.56% | +14.00% | +52.00% | +80.95% | 17.20 M USD | ||
| 4638 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.09 USD | +2.83% | -1.80% | +22.47% | -54.39% | 16.14 M USD | ||
| 4648 | PLUR Pluri Inc. - Common Stock | 1.47 USD | -3.92% | -6.37% | -5.16% | -61.54% | 15.86 M USD | ||
| 4649 | NCEL NewcelX Ltd. - Ordinary Shares | 3.28 USD | +2.82% | -6.29% | -9.14% | -35.43% | 15.74 M USD |